About
About Dynatronics Corporation
Dynatronics Corporation, a medical device company, designs, develops, manufactures, markets, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States, Asia, Latin America, the Middle East, and internationally. It offers orthopedic soft bracing products, including cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. The company also offers physical therapy and rehabilitation products, which include therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, traction, hot and cold therapy, and electrodes; and treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, and other related equipment. The company markets its products under the Dynatron, Dynatron Solaris, Bird & Cronin, Hausmann, PROTEAM, and Mammoth brand names. It sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and retail distributors and equipment manufacturers through a network of independent dealers. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota. On January 9, 2026, Dynatronics Corporation, filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Bird & Cronin, Hausmann, PROTEAM, and Mammoth brand names. It sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and retail distributors and equipment manufacturers through a network of independent dealers. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota. On January 9, 2026, Dynatronics Corporation, along with its affiliates, filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bank
Visit company website
5 years, 4 months ago
Dynatronics Corporation is currently in a long term uptrend where the price is trading 8.3% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.3.
Dynatronics Corporation's total revenue sank by 21.2% to $12M since the same quarter in the previous year.
Its net income has dropped by 388.8% to $-673K since the same quarter in the previous year.
Finally, its free cash flow grew by 80.2% to $1M since the same quarter in the previous year.
Based on the above factors, Dynatronics Corporation gets an overall score of 3/5.